With a foundation in oral solids, the addition of liquids in 2007 and expanding into controlled substances, high potency and hormonal products in 2008, the Amneal product offering continues to diversify along with our aggressive growth plan. This strategy involves proactive pursuit of technology transfers, ANDA acquisitions, site transfers and joint ventures—in addition to our own robust development pipeline-to expand our portfolio. Amneal now lists assets of over 250 products approved or filed with the US FDA and in development, including controlled substances, hormonal products, high potency formulations, soft gelatin capsules, liquids, oral solids, and a venture into the ophthalmic category.
Check out our Amneal Catalog of highest quality generic products. The listing offers CPSIA certificates, high and low resolution JPG product images, PDFs of our product labels, prescribing information/package outserts and more for anyone wanting the detail on our fine generic pharmaceuticals.
You'll notice that all of our products feature pharmacist-defined labels designed to assist in the reduction of dispensing errors and add efficiency to filling prescriptions. Visit the Label Logic page to learn more about this packaging innovation.